| DB ID | MyCo_1794 |
| Title | Humoral immune responses against facultative pathogen Candida utilis in atopic patients with vulvovaginal candidiasis. Candida utilis glucomannan - New serologic biomarker |
| Year | 2021 |
| PMID | 34826687 |
| Fungal Diseases involved | Vulvovaginal candidiasis |
| Associated Medical Condition | Atopic patients |
| Genus | Candida |
| Species | utilis |
| Organism | Candida utilis |
| Ethical Statement | The open research study and the study protocol have been approved previously by the Ethical Committee of the Oncology Institute of St. Elisabeth, Bratislava, Slovakia (15.12.2010). |
| Site of Infection | Vagina |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Glucomannan |
| Biomarker Full Name | Glucomannan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Slovakia |
| Cohort | The serological assays were performed in a patient cohort comprising 35 female participants (31.3 ±5.2 years) with atopy and a history of recurrent vaginal mycosis (Department of Clinical Immunology and Allergy, Oncology Institute of St. Elisabeth, Bratislava, Slovakia). |
| Cohort No. | 35 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | ELISA anti-Candida II and ELISA anti-ASCA Kit (Biogema, Slovakia). |
| Assay Data | None |
| Validation Techniques used | ELISA |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
